DZS INC.: Nasdaq/NYSE listing notice — DZS receives Nasdaq delisting determination for late 10-Qs; plans hearing by Feb 13

DZS INC.

Received Staff Delisting Determination on Feb 6, 2024 for failing to file Q2 and Q3 2023 Form 10-Qs by Feb 5 extension deadline.
Trading suspension not immediate; must request hearing by Feb 13, 2024 to stay delisting.
Hearing request automatically stays trading suspension for 15 days; company will seek extension until Aug 3, 2024.
Delinquent reports cause is a previously disclosed restatement; no assurance of timely filing within any extension.
Working on financial statements for restated periods, delinquent reports, and FY2023; subject to audit/review.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

DZS INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

February 6, 2024, DZS Inc. (the “Company”) received a Staff Delisting Determination (the “Staff Determination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq has initiated a process that could result in the delisting of the Company’s securities from Nasdaq as a result of the Company not being in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). The Staff Determi

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001101680-24-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.